Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study
<p>Abstract</p> <p>Background</p> <p>Studies have shown that early detection and treatment of neovascular age-related macular degeneration (NV-AMD) can delay vision loss and blindness. The objective of this study was to evaluate the efficacy/safety of intravitreal pegap...
Main Authors: | Xu Xiao, Wirostko Barbara M, Weber Pamela A, Goss Thomas F, Zlateva Gergana |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-02-01
|
Series: | BMC Ophthalmology |
Online Access: | http://www.biomedcentral.com/1471-2415/10/2 |
Similar Items
-
CLINICAL OUTCOMES OF THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH PEGAPTANIB
by: M. Burova, et al.
Published: (2015-12-01) -
Clinical outcomes of the treatment of exudative age-related macular degeneration with Pegaptanib
by: M. Burova, et al.
Published: (2013-02-01) -
Role of pegaptanib sodium in the treatment of neovascular age-related macular degeneration
by: Sobha Sivaprasad
Published: (2008-06-01) -
Pegaptanib Sodium versus Pegaptanib Sodium Combined with Macular Laser Photocoagulation or Laser Alone for Diabetic Macular Edema
by: G. Querques, et al.
Published: (2009-01-01) -
Comparison of the effect between pegaptanib and ranibizumab on exudative age-related macular degeneration with small lesion size
by: Fujihara M, et al.
Published: (2012-03-01)